Vertex's cystic fibrosis therapy meets goal of late-stage studies

Vertex Pharmaceuticals Inc said on Wednesday its triple-combination therapy showed improvement in lung function for people with cystic fibrosis (CF) in two late-stage studies.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news